Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02635347 · ClinicalTrials.gov registry record · NA

Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT02635347: Completed NA study, sponsored by Rutgers, The State University of New Jersey.

NCT02635347 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02635347, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

This study will assess the feasibility of lower limb-ischemia induced Remote Ischemic Conditioning (RIC) in the perioperative period before, during, and after Orthotopic Liver Transplantation (OLT). Remote ischemic conditioning will consist of 3 cycles of 5 minutes of lower limb ischemia induced via a mid-thigh pneumatic tourniquet, followed by 5 minutes of reperfusion. Interventions will take place after anesthesia induction but before surgery, at the completion of the procedure, and on the mornings of post-operative days 1-4.

Primary Outcome

Proportion of enrolled liver recipients that complete all 6 remote ischemic conditioning (RIC) interventions.

Interventions

  • PROCEDURE Remote Ischemic Conditioning (RIC)
  • DEVICE Pneumatic tourniquet

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2015-11
Est. Completion 2017-12-31
Phase NA

What the finished NCT02635347 record still lists

NCT02635347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Remote Ischemic Conditioning (RIC) is the first listed.

NCT02635347 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02635347 about?

NCT02635347 is a clinical study titled "Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study". This study will assess the feasibility of lower limb-ischemia induced Remote Ischemic Conditioning (RIC) in the perioperative period before, during, and after Orthotopic Liver Transplantation (OLT). Remote ischemic conditioning will consist of 3 cycles of 5 minutes of lower limb ischemia induced via...

What is the current status of trial NCT02635347?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2015-11. Estimated completion is 2017-12-31.

What interventions are being tested in trial NCT02635347?

The interventions under investigation include: Remote Ischemic Conditioning (RIC) (PROCEDURE), Pneumatic tourniquet (DEVICE).

Who is sponsoring clinical trial NCT02635347?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02635347's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02635347, the US trial registry maintained by the National Library of Medicine. NCT02635347 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.